Tuesday, December 20, 2016

Pharma Reviews: Price collusion charges of US DoJ may impact Indian pharma cos adversely: ICRA

“Nonetheless, such increased generic pricing related scrutiny is a concern for Indian pharmaceutical companies; and given the heightened focus on ...
Read more: Price collusion charges of US DoJ may impact Indian pharma cos adversely: ICRA